ReviewCurrent atherosclerosis reports2017

ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen.

Natalia A Rocha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.